Satsuma Pharmaceuticals Inc (STSA) Stock Analyst Earnings Estimates
NASDAQ:STSA - Nasdaq - US80405P1075 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 293.58% | N/A 37.17% | N/A 51.73% | N/A 10.04% | N/A -20.88% | N/A 10.41% | |||||||
| EBITDA YoY % growth | -4.94M | -7.46M -51.01% | -28.74M -285.25% | -48.09M -67.33% | -50.773M -5.58% | -58.708M -15.63% | N/A 34.24% | N/A 42.54% | N/A 78.62% | N/A 59.14% | N/A 294.74% | N/A 137.84% | N/A 36.36% | N/A 28.33% | |
| EBIT YoY % growth | -4.95M | -7.52M -51.92% | -28.88M -284.04% | -48.33M -67.35% | -51.166M -5.87% | -59.218M -15.74% | N/A 43.09% | N/A 15.65% | N/A -40.41% | N/A 99.29% | N/A 2,216.76% | N/A 228.30% | N/A -39.91% | N/A 18.05% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.74 51.77% | -1.77 35.40% | -2.19 -23.73% | N/A 56.57% | N/A 37.27% | N/A 45.73% | N/A 81.10% | N/A 150.00% | N/A 133.33% | N/A 42.86% | N/A 30.00% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.28 46.55% | -0.21 55.38% | -0.16 76.69% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.956M 45.39% | -7.308M 52.57% | -5.968M 49.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.31 36.73% | -0.30 | -0.01 | -3.02% |
| Q4 2022 Q2Q % growth | -0.70 -42.86% | -0.37 | -0.33 | -89.37% |
| Q3 2022 Q2Q % growth | -0.48 -14.29% | -0.55 | 0.07 | 13.37% |
| Q2 2022 Q2Q % growth | -0.52 -36.84% | -0.50 | -0.02 | -4.04% |
| Q1 2022 Q2Q % growth | -0.49 -2.08% | -0.50 | 0.01 | 2.62% |
| Q4 2021 Q2Q % growth | -0.49 31.94% | -0.49 | 0.00 | 0.95% |
| Q3 2021 Q2Q % growth | -0.42 39.13% | -0.52 | 0.10 | 19.26% |
| Q2 2021 Q2Q % growth | -0.38 41.54% | -0.42 | 0.04 | 9.87% |
| Q1 2021 Q2Q % growth | -0.48 29.41% | -0.43 | -0.05 | -12.94% |
| Q4 2020 Q2Q % growth | -0.72 -16.13% | -0.54 | -0.18 | -33.50% |
| Q3 2020 Q2Q % growth | -0.69 69.47% | -0.71 | 0.02 | 2.61% |
| Q2 2020 Q2Q % growth | -0.65 | -0.73 | 0.08 | 10.66% |
| Q1 2020 Q2Q % growth | -0.68 | -0.68 | 0.00 | 0.50% |
| Q4 2019 Q2Q % growth | -0.62 | -0.82 | 0.20 | 24.49% |
| Q3 2019 Q2Q % growth | -2.26 | -1.03 | -1.23 | -119.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10.1% | -6.45% | 0% | -39.18% |
| Revenue | N/A | N/A | N/A | N/A |